Genetically Unmodified Cytotoxic T Lymphocyte Therapy for Viral Infections, their Sequelae & Cancer

Описание: Speaking at Cell and Gene Therapy 2025, Dr. Neal Flomenberg, Chief Science Officer at Tevogen Bio, presented his talk on genetically unmodified T lymphocyte therapy for viral infections and cancer.

During Dr. Flomenberg’s talk, he discusses early clinical trial data and the potential benefit of these cells in treating various disease modalities.